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Abstract
Background: Inappropriate antibiotic use promotes resistance. Antibiotics are generally not
indicated for upper respiratory infections (URIs). Our objectives were to describe patterns of URI
treatment and to identify patient and provider factors associated with antibiotic use for URIs.
Methods: This study was a cross-sectional analysis of medical and pharmacy claims data from the
Pennsylvania Medicaid fee-for-service program database. We identified Pennsylvania Medicaid
recipients with a URI office visit over a one-year period. Our outcome variable was antibiotic use
within seven days after the URI visit. Study variables included URI type and presence of concurrent
acute illnesses and chronic conditions. We considered the associations of each study variable with
antibiotic use in a logistic regression model, stratifying by age group and adjusting for confounders.
Results: Among 69,936 recipients with URI, 35,786 (51.2%) received an antibiotic. In all age
groups, acute sinusitis, chronic sinusitis, otitis, URI type and season were associated with antibiotic
use. Except for the oldest group, physician specialty and streptococcal pharyngitis were associated
with antibiotic use. History of chronic conditions was not associated with antibiotic use in any age
group. In all age groups, concurrent acute illnesses and history of chronic conditions had only had
fair to poor ability to distinguish patients who received an antibiotic from patients who did not.
Conclusion: Antibiotic prevalence for URIs was high, indicating that potentially inappropriate
antibiotic utilization is occurring. Our data suggest that demographic and clinical factors are
associated with antibiotic use, but additional reasons remain unexplained. Insight regarding reasons
for antibiotic prescribing is needed to develop interventions to address the growing problem of
antibiotic resistance.
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Background
Upper respiratory tract infections (URIs) are one of the
most frequent reasons patients see their physicians. [1]
Antibiotics are generally not indicated for the treatment of
URIs as the etiology is usually viral and antibiotics have
no demonstrated benefit [1-5]. Recognition of this prob-
lem has resulted in numerous efforts to reduce the use of
antibiotics in patients with URI, in large part to stem the
recent increases in the prevalence of antibiotic resistant
organisms[4,6,7]. Inappropriate use of antibiotics also
leads to an unnecessarily high incidence of adverse drug
reactions and additional costs with few benefits. Despite
this knowledge, physicians continue to prescribe antibiot-
ics in more than 45% of URI episodes [8-10].
Although other studies have explored factors associated
with antibiotic use for URIs, few studies have examined
the importance of comorbidity [11-14]. In fact, little
information is available regarding the importance of
comorbidity using administrative claims databases. The
objectives of this study were to describe patterns of upper
respiratory tract infection treatment and to identify
patient factors and provider specialties associated with
antibiotic use. In particular, since some comorbid condi-
tions and comorbid acute illnesses may justify the use of
antibiotics for URI episodes, we were interested in the pre-
dictive power of comorbid chronic conditions and comor-
bid acute illnesses for antibiotic use in URIs.
Methods
This study was a cross-sectional analysis of medical and
pharmacy claims data from the Pennsylvania Medicaid
fee-for-service program database. The study population
comprised patients in the Pennsylvania Medicaid fee-for-
service program (i.e., those not enrolled in a Medicaid
health maintenance organization) with a diagnosis of
URI. Patients were selected based on medical claims from
June 1, 1999 through May 31, 2000, with an office visit
coded with one of the following International Classification
of Diseases,Ninth Revision, Clinical Modification [15] diag-
nostic codes indicating a respiratory tract infection: acute
nasopharyngitis (460); acute pharyngitis, excluding strep-
tococcal pharyngitis (462); acute URI of multiple or
unspecified sites (465); acute laryngopharyngitis (465.0);
acute URI, multiple sites (465.8); acute URI, unspecified
site (465.9); acute bronchitis (466.0); influenza with
other respiratory manifestations (487.1) and bronchitis
not otherwise specified (490).
Since the unit of analysis was the patient and to avoid
duplication of patients in the analysis, we randomly
selected one URI episode for each patient during the study
period to be designated the index URI episode. To be
included in the study, patients must have been eligible for
Medicaid for at least seven days before and after the serv-
ice date of the index URI episode, to allow for the oppor-
tunity to observe antibiotic use and other acute conditions
temporally related to the URI episode.
Patient demographic information was linked to medical
and pharmacy claims files. Antibiotic prescription infor-
mation within seven days after the index URI episode was
extracted. The outcome variable was defined as evidence
of antibiotic use (yes/no) on the same day as, or within
seven days after the index URI episode date. The study var-
iables of interest were (1) presence of concurrent acute ill-
nesses (eight different variables indicating a diagnosis of
otitis media, streptococcal pharyngitis, pneumonia,
chronic sinusitis, acute sinusitis, urinary tract infection,
cellulitis or bacteremia, within seven days before or seven
days after the index URI episode); and (2) history of
comorbid chronic conditions (defined as presence of one
or more claims with a diagnosis of chronic bronchitis,
immunodeficiency including HIV/AIDS, solid organ
transplant or malignancy within one year prior to the
index URI episode) that might impact a physician's deci-
sion to prescribe an antibiotic. In addition, analysis
included evaluation of potential confounding factors
associated with antibiotic use, including the patient's age,
sex, race, county of residence (defined as one of six county
clusters), season of the URI episode (winter, spring, sum-
mer or fall) and specialty of the office visit physician asso-
ciated with the URI episode (defined as one of four
primary specialty groups: family medicine/internal medi-
cine/general practitioner; pediatrics; emergency medicine;
all other specialties).
Analyses were conducted using SAS® PC version 8.0 (SAS
Institute, Inc., Cary, North Carolina). Patient and provider
characteristics were categorized and compared using the
chi-square test. Logistic regression was used to estimate
the association of each study variable with the probability
of antibiotic use when adjusted for gender, race, physician
specialty and season of the URI episode. Odds ratios (OR)
and 95% confidence intervals (CI) are reported. Since age
modified the effect between antibiotic use and several of
the other independent variables, we report separate
regression models for four age groups (0 to 5 years, 6 to
21 years, 22 to 44 years and ≥ 45 years). The C statistic,
which estimates the area under the receiver-operating
characteristic (ROC) curve, was used to evaluate the abil-
ity of the presence of any concurrent acute illness (aggre-
gated into one dichotomous variable indicating the
presence or absence of any of the concurrent acute ill-
nesses) or history of chronic comorbid conditions to dis-
tinguish patients who received an antibiotic from patients
who did not, while controlling for gender, race, physician
specialty and season. Separate C statistics were calculated
for each age group stratification. The C statistic reports val-
ues from 0.5 (indicating no predictive power) to 1.0 (indi-BMC Infectious Diseases 2007, 7:47 http://www.biomedcentral.com/1471-2334/7/47
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cating perfect prediction)[16] Values of less than 0.7
generally indicate poor predictive power.
This analysis was completed as part of an ongoing retro-
spective drug utilization review (DUR) program for the
Pennsylvania Department of Public Welfare (DPW). The
DUR program work plan was approved by the University
of Maryland Institutional Review Board.
Results
Study Population
There were 69,936 unique Medicaid recipients with at
least one episode of a URI during the identification period
(Table 1). There were a total of 110,677 URI episodes; the
number of episodes per patient ranged from 1 to 55, with
a median and mode of 1 episode per patient. The mean
age was 21.5 (SD 20.4) years, and the median age was 16
years. The study population was primarily female (62.0%)
and white (83.9%). More than one third of the patients
had a URI episode occurring during the winter season.
Frequency and Characteristics of Antibiotic Treatment
Among the 69,936 recipients included in the analysis,
35,786 (51.2%) received an antibiotic on the same day as,
or within seven days after their index URI episode. Among
the patients who received an antibiotic, 27,656 (77.3%)
had an antibiotic prescription on the same day as the
index URI episode and 34,091 (95.3%) had an antibiotic
prescription within three days of the index URI episode.
Among those receiving an antibiotic, 33,900 (94.7%) had
only one antibiotic prescription; 1,815 (5.1%) had two
prescriptions, and 71 (0.2%) had three or four antibiotic
prescriptions on the same day or within seven days after
the index URI episode. When excluding the 10,012
patients with a concurrent acute illness that may have jus-
tified an antibiotic, antibiotic prevalence was 47.8%.
In the bivariate analysis, antibiotic use varied by age group
(p < 0.0001), with the lowest prevalence (44.9%) in the
youngest age group and the highest prevalence (56.2%) in
the oldest age group. The most frequently prescribed anti-
biotic was amoxicillin (36.9% of antibiotic prescriptions),
followed by azithromycin (19.6%), clarithromycin
(7.1%), amoxicillin/clavulanate (6.8%) and erythromy-
cin (5.1%).
Factors Associated with Antibiotic Use
The presence of any acute concurrent illness was signifi-
cantly associated with antibiotic use, the strength of asso-
ciation was greatest in the youngest age group (OR 4.63,
95% CI 4.29, 5.00). (Table 2). Across all age groups except
age > 45 years, physician specialty was significantly asso-
ciated with antibiotic use; family physicians and emer-
gency room physicians were more likely to be the
prescribing physician compared to other specialties and
pediatricians (data not shown).
For each age group, the independent effects of each of the
study variables of antibiotic use was analyzed using a mul-
tivariate logistic regression model, with antibiotic use
(yes/no) as the outcome variable (Table 2). After control-
ling for gender, race, physician specialty and season in
each age group, concurrent diagnoses of acute sinusitis,
chronic sinusitis and otitis media were associated with
antibiotic use, with the odds ratios for receiving an anti-
Table 1: Characteristics of Medicaid patients with an upper 
respiratory tract infection (URI) episode (n = 69,936)
Characteristic Number (%)
Age (years)
0–5 20,213 (28.9%)
6–21 21,843 (31.2%)
22–44 17,125 (24.5%)
45 and older 10,755 (15.4%)
Gender
Male 26,602 (38.0%)
Female 43,334 (62.0%)
Race
White 58,663 (83.9%)
Nonwhite 11,273 (16.1%)
Number of URI episodes in one year
1 46,765 (66.9%)
2 13,839 (19.8%)
3 or more 9,332 (13.3%)
Diagnosis of index URI episode
Acute bronchitis 19,344 (27.7%)
Common cold 1,818 (2.6%)
Influenza with respiratory symptoms 1,682 (2.4%)
Acute URI, other sites or not specified 47,092 (67.3%)
Presence of concurrent acute illnesses
Any acute condition 10,012 (14%)
Otitis media 5,505 (8)
Acute sinusitis 2,373 (3)
Chronic sinusitis 1,023 (1)
Pneumonia 575 (< 1)
Strep pharyngitis 540 (< 1)
Cellulitis 117 (< 1)
Urinary tract infection 68 (< 1)
Bacteremia 13 (< 1)
History of chronic comorbid conditions*
Yes 1,763 (2.5%)
No 68,173 (97.5%)
Physician specialty for index URI episode
Family practice, general practice or internal 
medicine
28,320 (40.5%)
Pediatrics 4,139 (5.9%)
Emergency medicine 4,411 (6.3%)
Other specialty 33,066 (47.3%)
Season of index URI episode
Winter 24,575 (35.1%)
Spring 15,786 (22.6%)
Summer 10,650 (15.2%)
Fall 18,925 (27.1%)
* One or more claims with a diagnosis of chronic bronchitis, 
immunodeficiency including HIV/AIDS, solid organ transplant or 
malignancy, one year prior to the index URI episode.BMC Infectious Diseases 2007, 7:47 http://www.biomedcentral.com/1471-2334/7/47
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biotic for each of theses acute illnesses highest in the
youngest age group.
In children ages 0 to 5 years, a concurrent diagnosis of oti-
tis media (OR 4.56, 95% CI 4.20, 4.95), streptococcal
pharyngitis (OR 3.12, 95% CI 2.10, 4.63), chronic sinusi-
tis (OR 4.01, 95% CI 2.93, 6.70), acute sinusitis (OR 3.85,
95% CI 2.69, 5.97) and pneumonia (OR 1.71, 95% CI
1.27, 2.29) increased the likelihood of receiving an anti-
biotic.
Patients aged 6 to 21 years were more likely to receive an
antibiotic for a URI if they had a concurrent diagnosis of
otitis media (OR 2.88, 95% CI 2.53, 3.28), chronic sinusi-
tis (OR 2.98, 95% CI 2.29, 3.88), acute sinusitis (OR 2.80,
95% CI 2.33, 3.36) streptococcal pharyngitis (OR 1.61,
95% CI 1.26, 2.06) and pneumonia (OR 1.93, 95% CI
1.28, 2.92). Additionally, this age group was more likely
to receive an antibiotic if there was a concurrent urinary
tract infection (OR 3.02, 95% CI 1.00, 9.14). In the 22 to
44 year old age group, four of the eight concurrent acute
respiratory illnesses were significantly associated with
antibiotic use for a URI [concurrent acute sinusitis (OR
1.90, 95% CI 1.68–2.17), chronic sinusitis (OR 2.02, 95%
CI 1.62–2.51), cellulitis (OR 2.19, 95% CI 1.11–4.33),
otitis media (OR 1.60, 95% CI 1.34–1.91)]. Concurrent
urinary tract infection (OR 2.95, 95% CI 1.17–7.45) was
also associated with antibiotic use. Concurrent acute ill-
nesses in the oldest group (age ≥ 45 years) that were asso-
ciated with antibiotic use included acute sinusitis (OR
2.17, 95% CI 1.75–2.68), chronic sinusitis (OR 1.94, 95%
CI 1.39–2.73), acute sinusitis (OR 2.17, 95% CI 1.75–
2.68) and otitis media (OR 1.70, 95% CI 1.21–2.41). A
history of chronic comorbid conditions (i.e., one or more
claims with a diagnosis of chronic bronchitis, immunode-
ficiency including HIV/AIDS, solid organ transplant or
malignancy, one year prior to the index URI episode) was
not associated with antibiotic use in any of the age groups.
The C statistic (area under the ROC curve) was used to
assess the ability of the presence of the regression models
to discriminate patients who received antibiotics from
those who did not. We report the C-statistics for the 'any
acute condition' models (models corresponding to the
first row of results in Table 2) and for the 'history of
chronic conditions' models (models corresponding to the
tenth row of results in Table 2). C statistics ranged from
0.54 (history of chronic comorbid conditions in the 22 to
44 year age group) to 0.67 (presence of concurrent acute
illness in the 0 to 5 year age group), suggesting that these
models have poor to fair predictive value.
Discussion
In the Pennsylvania Medicaid fee-for-service population
during the study period, over one-half of recipients with
an upper respiratory tract infection received an antibiotic
on the same day as or within seven days after a physician
visit for a URI. Even among those patients without a con-
current acute illness that may justify an antibiotic, anti-
biotic use was high (47.8%). These findings are consistent
Table 2: Adjusted odds ratios (OR) for antibiotic use in upper respiratory tract infections (URI) among Pennsylvania Medicaid fee-for-
service recipients, June 1, 1999 through May 31, 2000, by Age Group*
Odds Ratios for Antibiotic Use
Age 0 – 5 years Age 6 – 21 years Age 22 – 44 years Age ≥ 45 years
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Any concurrent acute illness 4.63 4.29–5.00 2.83 2.58–3.10 1.84 1.68–2.02 1.73 1.51–2.00
Acute Sinusitis 3.70 2.71–5.04 2.80 2.33–3.36 1.90 1.68–2.17 2.17 1.75–2.68
Bacteremia 2.11 0.50–8.88 -- -- 0.21 0.02–1.90 -- --
Cellulitis 1.41 0.63–3.15 1.38 0.61–3.14 2.19 1.11–4.33 0.90 0.44–1.84
Chronic Sinusitis 4.01 2.69–5.97 2.98 2.29–3.88 2.02 1.62–2.51 1.94 1.39–2.73
Otitis media 4.56 4.20–4.95 2.88 2.53–3.28 1.60 1.34–1.91 1.70 1.21–2.41
Pneumonia 1.71 1.27–2.29 1.93 1.28–2.92 1.18 0.84–1.64 0.96 0.68–1.35
Strep pharyngitis 3.12 2.10–4.63 1.61 1.26–2.06 1.39 0.95–2.05 0.76 0.31–1.84
Urinary tract infection 4.31 0.45–41.62 3.02 1.00–9.14 2.95 1.17–7.45 0.73 0.31–1.73
History of chronic conditions§ 1.47 0.96–2.27 1.06 0.75–1.51 1.10 0.93–1.29 1.11 0.97–1.28
URI Diagnosis
Influenza 1 Reference 1 reference 1 reference 1 reference
Common cold 1.64 1.20–2.25 1.27 0.96–1.67 1.42 1.07–1.88 1.07 0.75–1.53
Acute bronchitis 4.83 3.63–6.42 5.84 4.75–7.24 4.28 3.52–5.20 3.83 3.07–4.78
Other sites or not specified 1.74 1.32–2.30 2.46 2.00–3.02 2.54 2.09–3.08 2.17 1.73–2.71
CI denotes confidence interval.
--denotes OR cannot be calculated since there were no episodes of bacteremia.
*Adjusted for gender, race, physician specialty and season of URI. The probability of receiving an antibiotic at a visit was the dependent variable.
§Chronic conditions include chronic bronchitis, immunodeficiency including HIV/AIDS, solid organ transplant or malignancy.BMC Infectious Diseases 2007, 7:47 http://www.biomedcentral.com/1471-2334/7/47
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with other similar analyses, which found 44% to 60%
prevalence of antibiotic prescribing for colds or
URIs[8,9,17,18]. The high prevalence indicates that
potentially inappropriate antibiotic use is high and
should be a target for antibiotic education and manage-
ment to reduce excess use.
Antibiotic resistance is a worldwide public health issue,
resulting in emerging antimicrobial resistance and costing
$1.3 billion in the United States in 1992[19]. Unfortu-
nately, the extent of the problem is not fully realized since
surveillance of drug-resistance is limited[20]. Evidence for
a causal association between antimicrobial use and resist-
ance is supported by ecological data (changes in use par-
allel changes in prevalence of resistance). Also, there is
evidence of increased prevalence of resistance in nosoco-
mial strains compared to community-acquired strains,
association of prior antibiotic use with nosocomial out-
breaks and association of increased antibiotic use with
increased resistance rates[21,22].
To address prescribing factors, educational and adminis-
trative interventions have been proposed [23-31]. Admin-
istrative interventions are generally restrictive in nature
and include prior authorization, formulary restriction,
ordering forms and cycling. Educational interventions
may include dissemination of susceptibility information,
use of computer-based algorithms, and academic detail-
ing. An understanding of the factors contributing to
potentially inappropriate antibiotic use can help guide
policy makers to design an effective educational or admin-
istrative intervention.
Our findings suggest that the presence of certain concur-
rent acute illnesses increase the likelihood of antibiotic
use for a URI. It is possible those antibiotics were actually
prescribed for these other acute conditions and that the
URI was a coincidental diagnosis. Hence, it could be
argued that for some patients the prescription of antibiot-
ics may have been indicated.
However, antibiotic use was highly prevalent (47.8%)
even among those without a coincidental diagnosis. In
the final regression models coincidental diagnoses only
had fair to poor ability to distinguish patients who
received an antibiotic from patients who did not, as indi-
cated by the C statistics. Although the presence of illnesses
such as otitis media or streptococcal pharyngitis was sig-
nificantly associated with antibiotic use, they did not help
to discriminate patients who received an antibiotic during
a URI from those who did not. Thus, the reasons why phy-
sicians prescribe antibiotics for URIs is complex and is not
fully explained by regression models of this study. Several
reasons have been cited for inappropriate prescribing of
antibiotics. These include patient expectation, [32-35]
physicians' perception of patients' expectations,[32,35-
37] patients' lack of education,[35,38] and economic
pressure[35,38]. Our findings suggest that more research
is needed in understanding why antibiotics are being used
for URIs in adults, as well as in children.
This paper explored predictive factors of antibiotic use for
URI in an administrative database namely a Medicaid
population. The concurrent presence of an acute illness
such as cellulitis or UTI may explain the observed anti-
biotic prescription that was contemporaneous to a URI
episode. In addition, we chose to explore the importance
of comorbidity in predicting antibiotic use. For some
chronic comorbid conditions, such as chronic malignancy
or immunodeficiency, antibiotic use may be medically
indicated for URIs. Thus, we chose a limited number of
comorbid conditions, that we believe justified antibiotic
use. Other studies have used a wider range of comorbid
conditions that included diabetes, cardiovascular disease.
These additional comorbid conditions may be important
risk factors in that they increase antibiotic prescribing.
However, we chose not to include these additional condi-
tions because their presence generally does not justify
antibiotic use.
One limitation of this study was that validation of the
medical and prescription claims data against the primary
data in the actual medical record was not possible due to
limited resources. However, Medicaid prescription claims
tend to be a reliable source of drug availability[39].
Reimbursement is linked to accurate billing, though the
reliability of the diagnosis on the medical service claim is
less certain since diagnosis generally does not influence
reimbursement directly. This may result in misclassifica-
tion of URI-related events due to incorrect data entry or
wrong code assignment. For example, we included ICD-9-
CM code 490 (bronchitis not otherwise specified) in our
definition of URI; this code may also include patients with
COPD or acute exacerbation of chronic bronchitis. In
addition, the severity of the URI or the actual indication
for the antibiotic prescribed cannot be definitively deter-
mined from claims data. However, we did attempt to link
the antibiotic to the URI episode temporally and control
for other potential antibiotic indications in the analysis.
Another limitation is that there may be misclassification
of chronic disease history. Although we searched the
administrative claims for evidence of chronic conditions
for one year before the index URI episode, only 64% of
subjects were eligible for an entire year. However, when
we reran the 'history of chronic conditions' models for
only those subjects with one year of eligibility prior to the
URI episode, we obtained results to those in Table 2 (row
10), and nearly identical C statistics to the reported mod-
els.BMC Infectious Diseases 2007, 7:47 http://www.biomedcentral.com/1471-2334/7/47
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Finally, these findings may not be generalizable to popu-
lations other than Medicaid, since Medicaid patients are
differentiated by low economic status, source of care and
other factors that may affect drug utilization.
Conclusion
This analysis suggests that demographic and clinical fac-
tors are associated with the prescription of an antibiotic
for a URI, but much of the antibiotic use remains unex-
plained by acute illnesses and comorbid conditions. More
insight into the reasons for antibiotic prescribing needs to
be gained, which will lead to novel interventions that may
hopefully curb the growing problem of antibiotic resist-
ance.
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